Immunosuppressant and xanthine oxidase inhibitor

This page covers all Immunosuppressant and xanthine oxidase inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Purine synthesis pathway (azathioprine); xanthine oxidase (allopurinol).

Targets

Purine synthesis pathway (azathioprine); xanthine oxidase (allopurinol)

Phase 3 pipeline (1)

• Azathioprine and Allopurinol · Hvidovre University Hospital · Immunology
  Azathioprine suppresses the immune system by inhibiting purine synthesis, while allopurinol reduces uric acid production by inhibiting xanthine oxidase.

Patent intelligence

• immunosuppressant and xanthine oxidase inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates